Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for prevention of post-PRP macular edema
NCT00801866Phase 4Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Dec 2008
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in macular edema, sponsored by Asociación para Evitar la Ceguera en México. Planned start Dec 2008; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00801866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801866.